AgeCheck Woman

The AgeCheck Woman's anti-ageing check-up explores the effects of ageing in women by measuring the biomarkers most involved in the nutritional, hormonal and metabolic factors of this process.

Anti-ageing

What is AgeCheck Woman?

Ageing is responsible for physical, physiological and biological changes in women. It is important to detect the first signs of these variations in order to ensure that they are properly taken care of.

The AgeCheck Woman anti-ageing panel explores the effects of ageing in women by measuring the biomarkers most involved in the nutritional, hormonal and metabolic factors of this process.

What can we expect from AgeCheck Woman?

Aging is often accompanied by inconveniences that can be seen through biological variations: vitamin deficiencies, digestive difficulties, sleep or memory disorders… Latent candidiasis, an unbalanced and/or deficient diet, chronic fatigue can be the cause of biological dysfunctions and be accompanied by chronic inflammation, oxidative stress or dysbiosis.

Complementary to the “classic” hormone check-up routinely carried out by the general practitioner or gynaecologist, the biomarkers present in AgeCheck Woman will enable your practitioner to help you regain your well-being and vitality.

Who is AgeCheck Woman profile for?

AgeCheck Woman is intended for all women who are concerned about their metabolic balance and wish to prevent any signs of premature ageing.

Digestive problems, skin dryness, physical or psychological fatigue are all disturbances that the AgeCheck can help to resolve, by allowing an appropriate rebalancing of the body’s vital functions.

Parameters

CRP Ultrasensitive, Ferritin, Candida serology, IGF-1, DHEAS, Free T3, Vitamin D, Coenzyme Q10, Homocysteine

More information on AgeCheck Woman

Why does the AgeCheck Woman include these parameters specifically?

AgeCheck Woman brings together test parameters that can evaluate basic dysfunctions that may be encountered in a patient who wishes to optimise her health and well-being and minimise the effects of ageing: the following tests are performed:

  • ultra-sensitive CRP, whose elevation indicates the existence of low-grade inflammation,
  • ferritin, a measure of the body’s iron stores and an indicator of possible high-grade inflammation,
  • IGF-1 (somatomedin) and DHEA sulphate-with age, the decrease in levels often corresponds to a rough but real symptomatology (asthenia, libido disorders, mood disorders, etc.),
  • Vitamin D, a significant test parameter due to its multiple implications (bone/joint health but also immunity, inflammation, mood, cognition…),
  • free T3, representing the biologically active form of thyroid hormones, whose level depends closely on the conversion of free T4, itself conditioned by a sufficient quantity of co-factors including, in particular, iron and vitamin D, which are present in this balance,
  • coenzyme Q10, a fundamental antioxidant of the body and protector of the organism against free radical attacks,
  • homocysteine, a major player in the methylation processes essential to cellular metabolism, whose level may reflect a deficiency in vitamins B6, B9 or B12,
  • and Candida serology, which can point to the existence of a candidiasis which, often at low levels, disrupts the body’s immune function and accompanies dysbiosis or repeated infections.

For further reading...

De Jongh RT, van Schoor NM, Lips P. Changes in vitamin D endocrinology during aging in adults. Mol Cell Endocrinol. 2017;453:144‐150.

Samaras N, A review of age-related dehydroepiandrosterone decline and its association with well-known geriatric syndromes: is treatment beneficial?. Rejuvenation Res. 2013;16(4):285‐294.

Hernández-Camacho JD, Coenzyme Q10Supplementation in Aging and Disease. Front Physiol. 2018;9:44.

Herrmann J. Thyroid function and thyroid hormone metabolism in elderly people. Low T3-syndrome in old age?. Klin Wochenschr. 1981;59(7):315‐323.

Luukinen H. The relationships between high-sensitivity C-reactive protein and incident depressed mood among older adults. Scand J Clin Lab Invest. 2010;70(2):75‐79.